Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
High-Risk Breast Duct Epithelium

estradiol level of less than 40 pg/ml to document postmenopausal status. Both breasts must be free of any suspicious areas by physical examination and, for women over 30 years of age by mammogram

carcinoma
mammogram
BRCA1/2
ductal carcinoma in situ
BRCA1
  • 8 views
  • 28 Jul, 2021
  • 1 location
Advanced Diffusion Tensor MRI for Breast Cancer

The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.

  • 0 views
  • 09 Mar, 2021
  • 1 location
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

Neoadjuvant (preoperative) chemotherapy is an interesting research tool which allows investigators to test new drugs and/or new schedules with a validated surrogate endpoint, pCR. It also represents an ideal model to evaluate the relationships between treatments and tumor biomarkers. Recent publications have shown that new molecular classifications of breast cancer …

erbb2
carcinoma
carboplatin
anthracyclines
BRCA1
  • 0 views
  • 25 Jan, 2021
  • 1 location
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment

Breast cancer is the second leading cause of death for women around the world. Notably, most breast cancer patients die from tumor metastases in the liver, lungs, bones, or brain, not the primary tumor itself. Currently, clinicians are generally successful in treating primary tumors using standard protocols that are based …

primary tumor
mammogram
metastasis
  • 0 views
  • 25 Jan, 2021
  • 1 location